[124I]Meta-Iodobenzylguanidine

N/A

Report date: 2025/12/01 17:16:48
NME

Base Information

Drug Name[124I]Meta-Iodobenzylguanidine
Drug Alias Namemeta-[124I]iodobenzylguanidine[124I]mIBG
ClassificationRadiation-emitting products > Nuclides > Iodine > 124ISmall moleculesDiagnostic agent (In vivo) > Radionuclide Imaging agent +[5
Mechanisms of ActionPositron-emission tomography enhancers
TargetsUpdating
Therapy Area/IndicationsNeuroblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCancer Research UK
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCancer Research UK
Active IndicationsN/A
Inactive IndicationsNeuroblastoma

Other Information

ATC CodeN/A
Related LinksN/A